Green Synthesis: An Eco-Friendly Approach for the Synthesis of Silver Nanoparticles Functionalized with Operculina turpethum and It's In vitro and in vivo Biological Activities.

IF 6.6 2区 医学 Q1 NANOSCIENCE & NANOTECHNOLOGY
International Journal of Nanomedicine Pub Date : 2025-03-12 eCollection Date: 2025-01-01 DOI:10.2147/IJN.S507134
Saud Bawazeer
{"title":"Green Synthesis: An Eco-Friendly Approach for the Synthesis of Silver Nanoparticles Functionalized with <i>Operculina turpethum</i> and It's In vitro and in vivo Biological Activities.","authors":"Saud Bawazeer","doi":"10.2147/IJN.S507134","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Silver nanoparticles (AgNPs) have gained significant attention in biomedical applications. Green synthesis methods provide an eco-friendly and cost-effective approach to AgNPs production, utilizing plant extracts as reducing and stabilizing agents. In this study, AgNPs were synthesized using the methanolic extract of <i>Operculina turpethum</i>.</p><p><strong>Methodology: </strong>AgNPs were synthesized using <i>O. turpethum</i> extract, and their formation was confirmed through various analytical techniques. The antibacterial activity of both the crude extract and AgNPs was assessed against Staphylococcus aureus. Enzyme inhibition studies were conducted for urease, α-glucosidase, carbonic anhydrase II, and xanthine oxidase. Analgesic and sedative activities were evaluated through standard models.</p><p><strong>Results: </strong>AgNPs exhibited an inhibition zone of 14 mm against <i>S. aureus</i>, greater than the crude extract (12 mm) but lower than Linezolid (25 mm). Enzyme inhibition studies revealed strong activity, particularly against urease (96.09% inhibition, IC<sub>5o</sub> = 25.65 ± 0.97 µg/mL). AgNPs demonstrated superior analgesic effects (81.98% at 10 mg/kg), comparable to diclofenac sodium (86.02%). Sedative effects were dose-dependent, reaching 35.09% at 10 mg/kg.</p><p><strong>Discussion: </strong>The enhanced antibacterial activity of AgNPs suggests improved bioavailability and interaction with bacterial membranes. The strong enzyme inhibitory potential indicates their possible therapeutic role in enzyme-related disorders. The analgesic and sedative activity of AgNPs suggests their possible role in pain management agents and neuropharmacology. The results demonstrate the efficacy of green-synthesized AgNPs for biomedical applications.</p><p><strong>Conclusion: </strong>Green synthesized AgNPs and their antibacterial, enzyme inhibitory, analgesic, and sedative properties suggest promising therapeutic applications. Further research should explore their mechanisms and in vivo safety for clinical applications.</p>","PeriodicalId":14084,"journal":{"name":"International Journal of Nanomedicine","volume":"20 ","pages":"2991-3005"},"PeriodicalIF":6.6000,"publicationDate":"2025-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11911826/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Nanomedicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/IJN.S507134","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"NANOSCIENCE & NANOTECHNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Silver nanoparticles (AgNPs) have gained significant attention in biomedical applications. Green synthesis methods provide an eco-friendly and cost-effective approach to AgNPs production, utilizing plant extracts as reducing and stabilizing agents. In this study, AgNPs were synthesized using the methanolic extract of Operculina turpethum.

Methodology: AgNPs were synthesized using O. turpethum extract, and their formation was confirmed through various analytical techniques. The antibacterial activity of both the crude extract and AgNPs was assessed against Staphylococcus aureus. Enzyme inhibition studies were conducted for urease, α-glucosidase, carbonic anhydrase II, and xanthine oxidase. Analgesic and sedative activities were evaluated through standard models.

Results: AgNPs exhibited an inhibition zone of 14 mm against S. aureus, greater than the crude extract (12 mm) but lower than Linezolid (25 mm). Enzyme inhibition studies revealed strong activity, particularly against urease (96.09% inhibition, IC5o = 25.65 ± 0.97 µg/mL). AgNPs demonstrated superior analgesic effects (81.98% at 10 mg/kg), comparable to diclofenac sodium (86.02%). Sedative effects were dose-dependent, reaching 35.09% at 10 mg/kg.

Discussion: The enhanced antibacterial activity of AgNPs suggests improved bioavailability and interaction with bacterial membranes. The strong enzyme inhibitory potential indicates their possible therapeutic role in enzyme-related disorders. The analgesic and sedative activity of AgNPs suggests their possible role in pain management agents and neuropharmacology. The results demonstrate the efficacy of green-synthesized AgNPs for biomedical applications.

Conclusion: Green synthesized AgNPs and their antibacterial, enzyme inhibitory, analgesic, and sedative properties suggest promising therapeutic applications. Further research should explore their mechanisms and in vivo safety for clinical applications.

绿色合成:一种生态环保方法合成以大头草为功能化的银纳米粒子及其体内外生物活性。
银纳米颗粒(AgNPs)在生物医学应用中获得了极大的关注。绿色合成方法利用植物提取物作为还原剂和稳定剂,为生产AgNPs提供了一种既环保又经济的方法。本研究以猪皮草甲醇提取物为原料合成AgNPs。方法:以红花提取物为原料合成AgNPs,并通过各种分析技术证实其形成。测定了粗提物和AgNPs对金黄色葡萄球菌的抑菌活性。对脲酶、α-葡萄糖苷酶、碳酸酐酶II和黄嘌呤氧化酶进行了酶抑制研究。通过标准模型评估镇痛和镇静活性。结果:AgNPs对金黄色葡萄球菌的抑制范围为14 mm,大于粗提物(12 mm),小于利奈唑胺(25 mm)。酶抑制实验表明,对脲酶有较强的抑制作用(抑制率96.09%,ic50 = 25.65±0.97µg/mL)。AgNPs表现出较好的镇痛效果(10mg /kg时为81.98%),与双氯芬酸钠(86.02%)相当。镇静作用呈剂量依赖性,10 mg/kg时达到35.09%。讨论:AgNPs抗菌活性的增强表明其生物利用度和与细菌膜的相互作用得到改善。强大的酶抑制潜能表明它们可能在酶相关疾病中发挥治疗作用。AgNPs的镇痛和镇静活性表明它们可能在疼痛管理药物和神经药理学中发挥作用。结果证明了绿色合成AgNPs在生物医学应用中的有效性。结论:绿色合成的AgNPs及其抗菌、抑酶、镇痛、镇静等特性具有广阔的应用前景。进一步的研究应探讨其机制和临床应用的体内安全性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
International Journal of Nanomedicine
International Journal of Nanomedicine NANOSCIENCE & NANOTECHNOLOGY-PHARMACOLOGY & PHARMACY
CiteScore
14.40
自引率
3.80%
发文量
511
审稿时长
1.4 months
期刊介绍: The International Journal of Nanomedicine is a globally recognized journal that focuses on the applications of nanotechnology in the biomedical field. It is a peer-reviewed and open-access publication that covers diverse aspects of this rapidly evolving research area. With its strong emphasis on the clinical potential of nanoparticles in disease diagnostics, prevention, and treatment, the journal aims to showcase cutting-edge research and development in the field. Starting from now, the International Journal of Nanomedicine will not accept meta-analyses for publication.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信